Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA

Area of Science:

• Molecular Biology
• Gene Expression Regulation
• RNA Splicing

Background:

• Calcitonin (CT) and calcitonin gene-related peptide (CGRP) are derived from the same gene through alternative RNA processing.
• Tissue-specific expression of CT and CGRP relies on the differential inclusion or exclusion of specific exons during pre-mRNA splicing.
• Understanding the regulatory mechanisms of this alternative splicing is crucial for deciphering gene expression control.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the tissue-specific alternative splicing of the CT/CGRP pre-mRNA.
• To establish a model system for studying the regulation of exon 4 inclusion/exclusion.
• To identify potential splicing factors involved in this regulatory process.

Main Methods:

• Construction of a minigene containing key exons of the human CT/CGRP gene.
• Transfection of the minigene into HeLa and F9 teratocarcinoma cells.
• In vitro splicing assays using nuclear extracts from these cell lines.
• Analysis of mRNA products to determine splicing patterns.

Main Results:

• The minigene accurately reproduced tissue-specific alternative splicing in transfected HeLa (exon 4 inclusion) and F9 (exon 4 exclusion) cells.
• An in vitro system using nuclear extracts recapitulated the observed splicing patterns.
• Supplementing HeLa cell extract with F9 cell extract shifted the splicing outcome towards exon 4 exclusion.

Conclusions:

• A functional model system was developed to study CT/CGRP alternative splicing regulation.
• This system demonstrates the presence of cell-specific splicing factors that determine exon 4 usage.
• The model system provides a platform for purifying and characterizing novel splicing factors involved in this critical regulatory event.